I-131 MIBG Scintighraphy Localization of Pheochromocytoma In Maharat Nakhon Ratchasima Hospital: a Case Report and Literatures Review
Article Sidebar
Main Article Content
Abstract
Pheochromocytoma is unusual and rare tumor of the adrenal gland. It accounts for less than 1% of patients with hypertension. Early detection and removal of the tumor can cure the hypertension and its associated symptoms in about 90% cases, while the untreated patient is likely to be fatal due to catecholamine-induced malignant hypertension, heart failure, myocardial infarction, stroke, ventricular arrhythmia or metastasis. This report showed a case of Pheochromocytoma that occurred in 51 year-old male with history of hypertension and frequent symptoms of headache, palpitation and sweating. He has not been diagnosed until he developed complications in 4 years later. Then, he was diagnosed and treated.
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
References
Mc Ewan AJ, Shapiro B, Sisson JC, Beierwaltes WH, Ackery DM. Radio-iodobenzylguanidine for the Scintigraphic Localization and Therapy of Adrenergic Tumors. In: Freeman LM, editor. Freeman and Johnson's Clinical Radionuclide Imaging. 3rd ed. Florida: Grune & Stratton Inc; 1986. p.2028-57.
วัชรินทร์ รัตนมาศ. เวชศาสตร์นิวเดลียร์คลินิก. พิมพ์ครั้ง ที่1. กรุงเทพมหานคร: เรือนแก้วการพิมพ์; 2540.
Moreira SG, Jr, Pow-Sang JM. Evaluation and Management of Adrenal Masses. Cancer Control 2002;9:326-34.
Neumann HPH, Cybulla M, Shibata H, Oya M, Naruse M, Higashihara E, et al. New genetic causes of pheochromocytoma. Keio J Med 2005; 54:15-21.
Stewart MF, Reed P, Weinkove C, Moriarty KJ, Ralston AJ. Biochemical diagnosis of phacochromocytoma: two instructive case reports. J Clin Pathol 1993; 46: 280-2.
Lenders JWM, Pacak K, Walther MM, Linehan M, Mannelli M, Friberg P, et al. Biochemical diagnosis of pheochromocytoma. Which test is best? JAMA 2002; 287: 1427-34.
Sawka AM, Jaeschke R, Singh RJ, Young WF.A comparison of biochemical tests for pheochromocytoma: measurement of unfractionated plasma metanephrines compared with the combination of24-hour urinary metanephrines and catecholamines. J Clin Endocrinol Metab 2003;88:553-8.
Graaf JS de, Klooster NJJ, Lange WE de, Piers DA, Zwierstra RP. Comparison of Metaiodobenzylguanidine Scintigraphy and Computed Tomography for Localization of Phaeochromocytoma. Nederlands Tijdschrift voor Geneeskunde 1991; 135: 2383-7.
Radin DR, Ralls PW, Boswell WD, Jr, Colleti PM, Lapin SA, Halls JM. Pheochromocytorna: detection by unenhanced CT. AJR 1986; 146: 741-4.
Swensen SJ, Brown ML, Sheps SG, Sizemore GW, Gharib H, Grant CS, et al. Use of 131I-MIBG scintigraphy in evaluation of suspected pheochromocytoma. Mayo Clin Proc 1985; 60: 299-304.
Hoegerle S, Nitsche E, Altehoefer C, Ghanem N, Manz T, Brink I,et al. Pheochromocytomas: Detection with 18F DOPA Whole-Body PET-Initial Results. Radiology 2002;2222: 507-12.
Cecchin D, Lumachi F, Marzola MC, Opocher G, Scaroni C, Zucchetta P,et al. A meta-iodobenzylguanidine Scintigraphic Scoring System Increases Accuracy in the Diagnostic Management of Pheochromocytoma. Endocrine-Related Cancer 2006; 13: 525-33.